abstract |
The present invention also relates to compounds having the general formula II, optionally in the form of a pharmaceutically acceptable salt, solvate, polymorph, prodrug, tautomer, racemate, enantiomer or diastereomer, As a result, It is useful for treating, ameliorating or preventing viral diseases. In addition, certain combinations of therapies are disclosed. |